Monday, April 15, 2024
Home Tags Study

Tag: study

Ministry refuses launch of research on proposed subsea cable : Cayman...

0
Existing Maya-1 undersea cable (CNS): The planning and infrastructure ministry has released some documents relating to the proposed new undersea communications cable and the...

‘Positive results from PK study with cobitolimod’ selected as one of...

0
STOCKHOLM, Aug. 22, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the positive results from the pharmacokinetic (PK) study with...

Huntington Study Group Welcomes FDA Approval of New Drug for Chorea...

0
Rochester, NY August 18, 2023 --(PR.com)-- The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world...

Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in...

0
NEWARK, N.J. and NANJING, China, July 31, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2...

Global Times: Beautiful China as a case study for developing nations...

0
BEIJING, July 25, 2023 /PRNewswire/ -- At a national conference on ecological and environmental protection held from Monday to Tuesday, Chinese President Xi...

ENB Therapeutics Presents Top-line Results from Phase 1b ENBOLDEN-101 Study in...

0
ENB is developing first in class small molecule ENB-003 to selectively targeting the ETB receptor - a novel immune checkpoint  The ENB-003 in combination...

Arrowhead Presents Updated Data from Phase 2 SEQUOIA Study of Investigational...

0
- Data Presented During Oral Session at EASL 2023 Demonstrate Fazirsiran's Promising Impact on Key Markers of Liver Disease - AATD-LD is a Rare...

New ENRICH-PLUS Study Builds on World’s First Positive Clinical Trial for...

0
NICO awards University of Maryland $200,000 for first-of-its-kind study combining MIPS with neuroprotectant for basal ganglia ICHINDIANAPOLIS, June 22, 2023 /PRNewswire/ -- Just two...

Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology of First…...

0
Modifying patients' T-cells with mRNA to express a chimeric antigen receptor (rCAR-T therapy) a novel approach to treat myasthenia gravis and other autoimmune...

First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring...

0
MELBOURNE, Australia, June 18, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited TLX Telix, the Company) today announces that the first patient has been dosed in...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News